Infectious Diseases Learning Unit: Understanding Advances in the Treatment of Latent Tuberculosis Infection Among People With Human Immunodeficiency Virus.

Mehtani, Nicky J; Puryear, Sarah; Pham, Paul; Dooley, Kelly E; Shah, Maunank

Mehtani, Nicky J; Puryear, Sarah; Pham, Paul; Dooley, Kelly E; Shah, Maunank.

Afiliación

Mehtani NJ; University of California, San Francisco, Department of Medicine, Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, California, USA.
Puryear S; University of California, San Francisco, Department of Medicine, Division of HIV, Infectious Diseases, and Global Medicine, San Francisco, California, USA.
Pham P; Johns Hopkins University, Department of Medicine, Division of Infectious Diseases, Baltimore, Maryland, USA.
Dooley KE; Johns Hopkins University, Department of Medicine, Division of Clinical Pharmacology, Baltimore, Maryland, USA.
Shah M; Johns Hopkins University, Department of Medicine, Division of Infectious Diseases, Baltimore, Maryland, USA.

Open Forum Infect Dis ; 8(8): ofab319, 2021 Aug.

Article en En | MEDLINE | ID: mdl-34395707

Palabras clave

HIV; latent tuberculosis infection; rifamycin

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Open Forum Infect Dis Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google